Want to join the conversation?
$APOG said the company continues to expect about 10% revenue growth for the year. The company said backlog in 1Q17 grew both sequentially and YoverY, exceeding $1.5Bil in backlog for four straight quarters. $APOG is expecting backlog to continue to grow for FY17 YoverY.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)